Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| LifeStance Health Group, Inc.LFST · Entity 3936 | Chief Medical Officer | June 16, 2025 | June 18, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
LifeStance Health Group, Inc.
Report date June 16, 2025 · Filed June 18, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 103,916 |
Reported balance
After 2025-06-16 transaction · row 1
1 source rowRow 1 · 2025-06-16 · Sale · Disposed 9,519 · Balance 103,916 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 16, 2025 Filed Jun 18, 2025 16:00 UTC | LifeStance Health Group, Inc. LFST · Entity 3936 | SaleCommon Stock | 9,519 | $5.17 | $49,213.23 |
DisclosureSEC source: 0000950170-25-087871 · ownership.xml · nonDerivative · entry 1 Ramtekkar Ujjwal · CIK 0002009235 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 103,916 Read SEC document |
| June 05, 2025 Filed Jun 9, 2025 17:00 UTC | LifeStance Health Group, Inc. LFST · Entity 3936 | SaleCommon Stock | 16,000 | $5.94 | $95,040.00 |
DisclosureSEC source: 0000950170-25-083828 · ownership.xml · nonDerivative · entry 1 Ramtekkar Ujjwal · CIK 0002009235 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 113,435 F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $5.93 to $5.945 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| March 10, 2025 Filed May 19, 2025 20:45 UTC | LifeStance Health Group, Inc. LFST · Entity 3936 | Tax withholdingCommon Stock | 4,346 | $7.11 | $30,900.06 |
DisclosureSEC source: 0000950170-25-074771 · ownership.xml · nonDerivative · entry 1 Ramtekkar Ujjwal · CIK 0002009235 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 129,435 F1 · kind: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the net settlement of RSUs that vested on March 10, 2025. The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested RSUs and do not constitute any open-market sale. Read SEC document |
| March 07, 2025 Filed Mar 10, 2025 20:46 UTC | LifeStance Health Group, Inc. LFST · Entity 3936 | Tax withholdingCommon Stock | 6,544 | $7.59 | $49,668.96 |
DisclosureSEC source: 0000950170-25-036728 · ownership.xml · nonDerivative · entry 3 Ramtekkar Ujjwal · CIK 0002009235 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 133,781 F3 · kind: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the net settlement of PSUs that vested on March 7, 2025. The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested PSUs and do not constitute any open-market sale. Read SEC document |
| March 07, 2025 Filed Mar 10, 2025 20:46 UTC | LifeStance Health Group, Inc. LFST · Entity 3936 | GrantCommon Stock | 20,805 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-036728 · ownership.xml · nonDerivative · entry 2 Ramtekkar Ujjwal · CIK 0002009235 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 140,325 F2 · shares: Represents performance-based restricted stock units ("PSUs") previously granted to the Reporting Person on March 8, 2024, which vested on March 7, 2025. Read SEC document |
| March 06, 2025 Filed Mar 10, 2025 20:46 UTC | LifeStance Health Group, Inc. LFST · Entity 3936 | GrantCommon Stock | 57,107 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-036728 · ownership.xml · nonDerivative · entry 1 Ramtekkar Ujjwal · CIK 0002009235 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 119,520 F1 · shares: Includes 57,107 restricted stock units ("RSUs") granted on March 6, 2025. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| March 08, 2024 Filed Mar 12, 2024 21:54 UTC | LifeStance Health Group, Inc. LFST · Entity 3936 | GrantCommon Stock | 62,413 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-030469 · ownership.xml · nonDerivative · entry 1 Ramtekkar Ujjwal · CIK 0002009235 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,413 F1 · shares: Includes 62,413 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.